Abstract:Coronavirus disease 2019 (COVID-19) is an emerging life-threatening pulmonary disease caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which originated in Wuhan, Hubei Province, China, in December 2019. COVID-19 develops after close contact via inhalation of respiratory droplets containing SARS-CoV-2 during talking, coughing, or sneezing by asymptomatic, presymptomatic, and symptomatic carriers. This virus evolved over time, and numerous genetic variants have been reported to have increased disease severity, mortality, and transmissibility. Variants have also developed resistance to antivirals and vaccination and can escape the immune response of humans. Reverse transcription polymerase chain reaction (RT–PCR) is the method of choice among diagnostic techniques, including nucleic acid amplification tests (NAATs), serological tests, and diagnostic imaging, such as computed tomography (CT). The limitation of RT–PCR is that it cannot distinguish fragmented RNA genomes from live transmissible viruses. Thus, SARS-CoV-2 isolation by using cell culture has been developed and makes important contributions in the field of diagnosis, development of antivirals, vaccines, and SARS-CoV-2 virology research. In this research, two SARS-CoV-2 strains were isolated from four RT–PCR-positive nasopharyngeal swabs using VERO E6 cell culture. One isolate was cultured successfully with a blind passage on day 3 post inoculation from a swab with a Ct > 35, while the cells did not develop cytopathic effects without a blind passage until day 14 post inoculation. Our results indicated that infectious SARS-CoV-2 virus particles existed, even with a Ct > 35. Cultivable viruses could provide additional consideration for releasing the patient from quarantine. The results of the whole genome sequencing and bioinformatic analysis suggested that these two isolates contain a spike 68-76del+spike 675-679del double-deletion variation. The double deletion was confirmed by amplification of the regions spanning the spike gene deletion using Sanger sequencing. Phylogenetic analysis revealed that this double-deletion variant was rare (one per million in public databases, including GenBank and GISAID). The impact of this double deletion in the spike gene on the SARS-CoV-2 virus itself as well as on cultured cells and/or humans remains to be further elucidated.

Possible Recombination Between Two Variants of Concern in a COVID-19 Patient

Corrigendum To: Genomic Diversity of Severe Acute Respiratory Syndrome–Coronavirus 2 in Patients with Coronavirus Disease 2019

Identification of Various Recombinants in a Patient Coinfected With the Different SARS‐CoV‐2 Variants

Investigation of the Genetic Variation in ACE2 on the Structural Recognition by the Novel Coronavirus (Sars-Cov-2)

Genotype Shift in Human Coronavirus OC43 and Emergence of a Novel Genotype by Natural Recombination

Recombinant SARS-CoV-2 Delta/Omicron BA.5 emerging in an immunocompromised long-term infected COVID-19 patient

Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events

Potential Inter‐variant and Intra‐variant Recombination of Delta and Omicron Variants

The Discovery of a Recombinant SARS2-like CoV Strain Provides Insights into SARS and COVID-19 Pandemics

Competitive fitness and homologous recombination of SARS‐CoV‐2 variants of concern

The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2

COVID-19: Understanding the New Variants of Concern

The nuts and bolts of recombination in the generation of SARS-CoV-2 variants; from XA to XBB

Comprehensive detection and dissection of interlineage recombination events in the SARS-CoV-2 pandemic

Both Simulation and Sequencing Data Reveal Coinfections with Multiple SARS-CoV-2 Variants in the COVID-19 Pandemic

Recombination Events Among SARS-CoV-2 Omicron Subvariants: Impact on Spike Interaction With ACE2 Receptor and Neutralizing Antibodies

Genomic epidemiology reveals early transmission of SARS-CoV-2 and mutational dynamics in Nanning, China

Systematic detection of co-infection and intra-host recombination in more than 2 million global SARS-CoV-2 samples

Isolation and Identification of a Rare Spike Gene Double-Deletion SARS-CoV-2 Variant From the Patient With High Cycle Threshold Value

Unraveling the genetic evolution of SARS-CoV-2 Recombinants using mutational dynamics across the different lineages

The concordance between the evolutionary trend and the clinical manifestation of the two SARS-CoV-2 variants